Mechanisms of Paclitaxel-Induced Apoptosis in an Ovarian Cancer Cell Line and Its Paclitaxel-Resistant Clone

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Oncology

• Publication date

  2004-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000076335PMID 15031599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of caspase activation and inhibition during apoptosis.

  2002cited by this paper
• p73α Overexpression Is Associated with Resistance to Treatment with DNA-damaging Agents in a Human Ovarian Cancer Cell Line

  2001cited by this paper
• Molecular signals in anti-apoptotic survival pathways

  2001cited by this paper
• P73a overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line.

  2001cited by this paper
• Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53

  2001cited by this paper
• Sensitivity to paclitaxel is not related to p53-dependent apoptosis in ovarian cancer cells.

  2000cited by this paper
• Resistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of antiapoptotic proteins in human cervical multidrug-resistant cells.

  2000cited by this paper
• Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines

  2000cited by this paper
• Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray.

  2000cited by this paper
• Optimum chemotherapy for ovarian cancer.

  2000cited by this paper
• Effects of interleukin-6 (IL-6) on chemotherapy-induced apoptosis in human ovarian cancer cell lines

  1999cited by this paper
• Apaf1 and the apoptotic machinery

  1999cited by this paper
• The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review

  1999cited by this paper
• Involvement of Microtubules in the Regulation of Bcl2 Phosphorylation and Apoptosis through Cyclic AMP-Dependent Protein Kinase

  1998cited by this paper
• Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy

  1998cited by this paper
• Paclitaxel (Taxol)-induced Gene Expression and Cell Death Are Both Mediated by the Activation of c-Jun NH2-terminal Kinase (JNK/SAPK)*

  1998cited by this paper
• Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines.

  1998cited by this paper
• Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death.

  1997cited by this paper
• Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line

  1997cited by this paper
• Taxol induces bcl-2 phosphorylation and death of prostate cancer cells.

  1996cited by this paper
• Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group).

  1996cited by this paper
• Enhanced interaction between tubulin and microtubule‐associated protein 2 via inhibition of MAP kinase and CDC2 kinase by paclitaxel

  1995cited by this paper
• Genotoxic stress confers preferential and coordinate messenger RNA stability on the five gadd genes.

  1994cited by this paper

• A Combination Delivery of Silver and Paclitaxel in Albumin Nanoparticles for Breast Cancer Cells

  2025influential citation
• Hydrogen Sulfide Treatment Enhanced Paclitaxel's Anticancer Effect on the ID8 Murine Epithelial Ovarian Cancer Cell Line

  2025cites this paper
• Comparative analysis of BAG1 and BAG2: Insights into their structures, functions and implications in disease pathogenesis.

  2024cites this paper
• Exploiting epigenetic targets to overcome taxane resistance in prostate cancer

  2023cites this paper
• Heat shock factor 1 suppression induces spindle abnormalities and sensitizes cells to antimitotic drugs

  2021cites this paper
• CIRCNV: Detection of CNVs Based on a Circular Profile of Read Depth from Sequencing Data

  2021cites this paper
• High‐throughput, microscope‐based sorting to dissect cellular heterogeneity

  2020cites this paper
• Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial.

  2020cites this paper
• LY2228820 induces synergistic anti-cancer effects with anti-microtubule chemotherapeutic agents independent of P-glycoprotein in multidrug resistant cancer cells.

  2019cites this paper
• Visual Cell Sorting: A High-throughput, Microscope-based Method to Dissect Cellular Heterogeneity

  2019cites this paper
• Effects of paclitaxel on permanent head and neck squamous cell carcinoma cell lines and identification of anti-apoptotic caspase 9b

  2016cites this paper
• Restoration of paclitaxel resistance by CDK1 intervention in drug-resistant ovarian cancer.

  2015cites this paper
• Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy.

  2015cites this paper
• Bag‐1 promotes cell survival through c‐Myc‐mediated ODC upregulation that is not preferred under apoptotic stimuli in MCF‐7 cells

  2015cites this paper
• Impact of α-Targeted Radiation Therapy on Gene Expression in a Pre-Clinical Model for Disseminated Peritoneal Disease when Combined with Paclitaxel

  2014cites this paper
• Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden

  2014cites this paper
• The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.

  2014cites this paper
• PCL films incorporated with paclitaxel/5-fluorouracil: Effects of formulation and spacial architecture on drug release.

  2012cites this paper
• Meta‐analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples

  2012cites this paper
• APAF1 (apoptotic protease activating factor 1)

  2011cites this paper
• Analysis of mitosis and antimitotic drug responses in tumors by in vivo microscopy and single-cell pharmacodynamics.

  2011cites this paper
• Impact of taxol on dermal papilla cells--a proteomics and bioinformatics analysis.

  2011cites this paper
• Midregion PTHrP and Human Breast Cancer Cells

  2010cites this paper
• Midregion PTHrP and Human Breast Cancer Cells

  2010cites this paper
• Proteasome Inhibition by Bortezomib Decreases Proliferation and Increases Apoptosis in Ovarian Granulosa Cell Tumors

  2009cites this paper
• Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel‐resistant phenotype

  2008cites this paper
• Synergy of a Herpes OncolyticVirus and Paclitaxel for AnaplasticThyroid Cancer

  2008cites this paper
• Reducing peritoneal vascular endothelial growth factor concentration and inhibiting cancer scattering in a mouse model of laparoscopy.

  2008cites this paper
• Unraveling the molecular targets of natural products: Insights from genomic and proteomic analyses

  2008cites this paper
• Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells.

  2008cites this paper
• Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer

  2008cites this paper
• Chapter 49 – Natural and Acquired Resistance to Cancer Therapies

  2008cites this paper
• Non-cytotoxic and sublethal paclitaxel treatment potentiates the sensitivity of cultured ovarian tumor SKOV-3 cells to lysis by lymphokine-activated killer cells.

  2007cites this paper
• BAG-4 / SODDand Associated Antiapoptotic Proteins Are Linked to Aggressiveness of Epithelial Ovarian Cancer

  2007cites this paper
• A snapshot of microarray-generated gene expression signatures associated with ovarian carcinoma

  2007cites this paper
• Growth inhibition and apoptosis induction in ovarian cancer cells : molecular mechanisms

  2007cites this paper
• BAG-4/SODD and Associated Antiapoptotic Proteins Are Linked to Aggressiveness of Epithelial Ovarian Cancer

  2007cites this paper
• Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines.

  2007cites this paper
• Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO

  2007cites this paper
• Molecular prognostic markers in ovarian cancer: toward patient‐tailored therapy

  2006cites this paper
• Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy

  2005cites this paper
• High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer.

  2005cites this paper
• High-Resolution Mapping of Genomic Imbalance and Identification of Gene Expression Profiles Associated with Differential Chemotherapy Response in Serous Epithelial Ovarian Cancer 1 *

  2005cites this paper
• Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells

  2005cites this paper
• Genome-wide transcriptional analysis of carboplatin response in chemosensitive and chemoresistant ovarian cancer cells

  2005cites this paper
• Emerging issues of the expression profiling technologies for the study of gynecologic cancer.

  2005cites this paper
• Using microarrays to predict resistance to chemotherapy in cancer patients.

  2004cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2002cites this paper